The concomitant use of general anesthetics may increase the risk of cardiac arrhythmias and seizures
Your doctor may decide to change the dose or sometimes discontinue one of the medications or take other precautions if necessary.
Use of Lioresal with food, drinks, and alcohol
Avoid drinking alcohol during treatment with Lioresal, as this may lead to an undesirable intensification or unpredictable change in the effects of the medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor before using this medication.
Pregnancy
There are no data or these are limited regarding the use of baclofen in pregnant women.
Your doctor will evaluate the possible risk of using Lioresal by the intrathecal route during pregnancy.
As a precaution, it is preferable to avoid the use of Lioresal by the intrathecal route during pregnancy.
Breastfeeding
Lioresal by the intrathecal route passes in very small amounts into breast milk.
No adverse effects are expected in infants/young children since systemic exposure to baclofen in lactating mothers is insignificant.You can breastfeed your child if your doctor allows it and always monitor the child for the possible appearance of adverse effects.
Baclofen may decrease milk production if used for a prolonged period.
Fertility
Studies in animals have shown that intrathecal baclofen is unlikely to produce adverse effects on fertility.
Driving and operating machinery
Lioresal by the intrathecal route may cause drowsiness, dizziness, vision problems, or clumsiness or instability in some people. If this happens, do not drive or use hazardous tools or machinery.
Lioresal contains sodium
This medication contains less than 1 mmolof sodium (23 mg) per ampoule (1 ml); this is essentially “sodium-free”.
If your doctor needs to dilute Lioresal with a saline solution, the sodium dose received would be higher.
Only a specially qualified doctor can administer Lioresal intrathecally.
Lioresal administered intrathecally is only given in the hospital through a pump placed under the skin of the abdomen. It can only be administered in the spinal canal (intrathecally).It should not be administered intravenously, intramuscularly, epidurally, or subcutaneously.
Lioresal is designed to be administered chronically by intrathecal infusion through a continuous release pump located in the abdomen. Through a prior testing phase, the appropriate dose of Lioresal for this chronic phase will have been determined. For the prior testing phase, the Lioresal 0.05 mg/ml presentation is used, which is administered in a single bolus via a spinal catheter or lumbar puncture intrathecally. Determining an appropriate dose for you may take several days under the supervision of a doctor.
If your muscle spasms improve with the test dose, a pump will be implanted under the skin of your abdomen, allowing for the continuous release of small amounts of the medication to control your symptoms.
Once the pump is implanted, the reservoir refill should be monitored to prevent it from being emptied. The refill should always be done in aseptic conditions to prevent possible microbial contamination.
It is very important that your doctor monitors the pump's functioning during regular visits.
It is essential that you maintain regular visits for the pump refill, as if you do not, your muscle spasms could reappear due to not receiving a sufficient dose of Lioresal.As a result, muscle spasticity may not improve and could even worsen.
The duration of treatment will be decided by your doctor. During long-term treatment, some patients observe a decrease in the efficacy of baclofen. Your doctor may recommend occasional breaks from treatment to counteract this phenomenon.
If muscle spasticity does not improve or if you start experiencing muscle spasms again, either gradually or suddenly,contact your doctor immediately..
If you are administered more Lioresal intrathecally than you should
You could experience an overdose. It is very important that you and your caregivers are able to recognize the symptoms of an overdose. These could appear suddenly, or slowly because the pump is not functioning correctly.
Themainsymptoms of an overdose are
- excessive muscle weakness (too low muscle tone),
- drowsiness,
- dizziness or vertigo,
- excessive salivation,
- nausea or vomiting,
- difficulty breathing,
- convulsions,
- loss of consciousness,
- abnormally low body temperature,
- rapid heart rate (tachycardia),
- ringing in the ears (tinnitus).
If you experience any of these symptoms, inform your doctor immediately..
If you interrupt the treatment with Lioresal intrathecally
If you have to stop treatment with this medication for any reason, your doctor will gradually reduce the dose to avoid the appearance of side effects.
The abrupt interruption or reduction of Lioresal intrathecal dose can cause withdrawal symptoms that in some cases have been fatal.It is very important that you and your caregivers are able to recognize the withdrawal symptoms of Lioresal intrathecal. These can appear suddenly, or slowly due to, for example, battery problems, catheter problems, alarm malfunction, or device malfunction.
Therefore :
The withdrawal symptoms are :
- severe and uncontrolled muscle spasms (too high muscle tone),
- difficulty moving muscles,
-rapid heart rate (tachycardia),
- low blood pressure,
- numbness or tingling in your hands or feet,
- anxiety,
- high fever,
- altered mental states such as agitation, confusion, hallucinations, abnormal behavior or thought, or convulsions.
- persistent and painful erection of the penis (priapism)
- infection (sepsis)
If you experience any of the above symptoms, seek medical attention immediately.These symptoms can be followed by more severe side effects (including death) if you do not receive immediate treatment.
If you have any other questions about the use of this medication, ask your doctor or nurse.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.,.
Side effects occur more frequently at the beginning of treatment during your stay in the hospital, but they may also occur later. Many of these side effects are associated with the medical condition for which you are being treated.
If you experience any of the following side effects, you should consult your doctor:
Some side effects can be serious
If you experience any of the side effects listed below, inform your doctor immediately:
If you experience any of these side effects,inform your doctor immediately.
Some side effects are very common(may affect more than 1 in 10 patients):
If you experience any of the mentioned side effects severely,inform your doctor.
Some side effects are common(may affect up to 1 in 10 patients):
If you experience any of the mentioned side effects severely,inform your doctor.
Some side effects are infrequent(may affect up to 1 in 100 patients):
Some side effects have unknown frequency:
Some of these side effects may be related to the pump delivery system.
For a description of withdrawal symptoms, see “If you interrupt treatment with Lioresal”.
For a description of overdose symptoms, see “If you are administered more Lioresal by intrathecal route than you should”.
Reporting side effects:
If you experience any type of side effect, consult your doctor or nurse, even if it is a possiblesideeffect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store below 30°C. Do not freeze.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.
Composition of Lioresal 0.05 mg/ml injectable solution
Appearance of the product and contents of the package
Lioresal 0.05 mg/ml is presented in the form of a clear and colorless solution for bolus administration.
Each package contains 5 ampoules.
Other presentations
Lioresal 0.5 mg/ml infusion solution. Package with 1 ampoule
Lioresal 2 mg/ml infusion solution. Package with 1 ampoule
Novartis Farmacéutica, S.A.
Gran Vía de les Corts Catalanes 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Roonstrasse 25
90429 Nürnberg
Germany
Novartis Farmacéutica, S.A.
Gran Vía de les Corts Catalanes, 764
08013 Barcelona
Spain
Last review date of this leaflet:August 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
<------------------------------------------------------------------------------------------------------------------------>
This information is intended solely for healthcare professionals: Consult the technical data sheet for more details on the medication, its dosage, and administration method.
Dosage
Recommended dose:
Test phase:
Adults
In adults, the initial test dose is 25 or 50 micrograms, which can be increased by 25 micrograms every 24 hours until a response is observed that lasts approximately 4-8 hours. The dose will be administered for at least 1 minute. For this test dose, ampoules of 0.05 mg/ml are available.
Pediatric population
The initial lumbar puncture in the test phase in patients aged 4 years and under 18 years should be 25 to 50 micrograms per day, depending on the age and height of the child. Patients who do not respond to this dose may receive an increase in dose of 25 micrograms every 24 hours. The maximum test dose should not exceed 100 micrograms/day in pediatric patients.
Dose determination phase:
The initial daily dose of Lioresal intratecal to be administered through the pump is determined by doubling the effective dose in the test phase and administering it for a period of 24 hours. If the effect of the test dose has been maintained for more than 12 hours, the initial dose should be the same as the test dose but administered for a period of 24 hours. No dose increases should be made during the first 24 hours of treatment. After the first 24 hours, the dose will be adjusted daily to achieve the desired clinical effect. Experience is limited with doses above 1,000 micrograms/day.
Maintenance phase:
The minimum dose required to achieve an adequate response should be used. Many patients need gradual increases in dose to maintain optimal response during chronic therapy due to reduced response to treatment or progression of the disease.
Preparation and handling of the product
Lioresal Intratecal is designed for intrathecal injection and continuous infusion as indicated in the administration specifications of the infusion system.
The specific concentration to be used depends on the total daily dose required as well as the release rate of the pump. Consult the manufacturer's manual for specific recommendations.
To patients who require concentrations other than 50 micrograms/ml, 500 micrograms/ml, or 2,000 micrograms/ml, Lioresal Intratecal must be diluted, in aseptic conditions, with sterile sodium chloride for injection and free of preservatives.
As a general rule, Lioresal 0.05 mg/ml ampoules for intrathecal administration should not be mixed with other infusion or injection solutions.
Glucose (dextrose) has been shown to be incompatible due to a chemical reaction that occurs with baclofen.
Administration devices
Different administration systems have been used for the prolonged intrathecal application of Lioresal. These include the Medtronic SynchroMed infusion pump system, which is an implantable drug delivery system with refillable reservoirs, which, after general or local anesthesia, are implanted in a subcutaneous cavity, usually in the abdominal wall.
This device is connected to an intrathecal catheter that passes subcutaneously to the subarachnoid space. Further details can be obtained from the manufacturer.
Before using other systems, it should be confirmed that the technical specifications, including the chemical stability of baclofen in the reservoir, meet the requirements for the intrathecal use of Lioresal.
Each ampoule is intended for single use. Discard any unused portion. Do not freeze. Do not sterilize with heat.
Stability
Lioresal Intratecal has been shown to be stable in the SynchroMed infusion pump system for 11 weeks. No stability data are available for Lioresal Intratecal when using other infusion systems.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.